This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Series A round totals $33mm for Flexion Therapeutics, which adds more later
04 Jun 2012
Drug development start-up Flexion Therapeutics has completed a $33mm Series A financing led by Versant Ventures, which also took part in the company's $3mm seed round in November 2007. Other founding investors participating in this round were 5AM Ventures and Sofinnova Partners. With a business model based on Lilly Research Lab division Chorus, Flexion hopes to take candidates through proof-of-concept faster and cheaper than the traditional development process. The company expects to soon announce partnerships it has in the works with three as-yet-unannounced pharmacos.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?